

(Sharecast News) - GSK said on Thursday that late-stage trial results for its experimental drug for chronic hepatitis B, bepirovirsen, showed that it ...


(Alliance News) - GSK PLC on Thursday reported "positive" phase 3 trial data for its hepatitis B treatment, Bepirovirsen, which it said could "redefin...


* GSK's drug helps 19% of patients achieve functional cure across two studies


(Sharecast News) - Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-...


(Alliance News) - GSK PLC on Monday announced that Japan's Ministry of Health, Labour & Welfare expanded the eligible population for its respiratory s...


(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.


(Alliance News) - GSK PLC on Monday launched the fifth tranche of its GBP2.0 billion buyback as it announced an exclusive collaboration with China pha...


(Sharecast News) - Drugmaker GSK said on Monday that it has struck an exclusive agreement with Sino Biopharmaceutical subsidiary Chia Tai Tianqing Pha...